ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,618.38
0.74%
US Tech 100
20,093.20
0.92%
Dow Jones
39,549.98
0.66%
Brent Oil
84.965
0.32%
Bitcoin
57,492.60
-0.91%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. GSK plc (GSK)

  7. GSK plc (GSK) News

GSK

GSK (GSK)

GSK plc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:GSK
DateTimeSourceHeadlineSymbolCompany
05/04/202310:31AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
05/03/20235:36PMValueWalkHaleon – Strong Start, But Pfizer To ExitNYSE:GSKGSK plc
05/03/20231:43PMDow Jones NewsGSK's RSV Vaccine Approved for Older Adults by FDANYSE:GSKGSK plc
05/03/20231:37PMBusiness WireUS FDA Approves GSK’s AREXVY, the World’s First Respiratory Syncytial Virus (RSV) Vaccine for Older AdultsNYSE:GSKGSK plc
04/28/202312:56PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
04/27/20236:51AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
04/26/202312:02PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
04/26/20235:43AMDow Jones NewsTrending: GSK Backs 2023 Guidance After 1Q BeatNYSE:GSKGSK plc
04/26/20233:05AMDow Jones NewsGSK 1Q Profit, Sales Beat Expectations But Fell On-Year; Backs 2023 GuidanceNYSE:GSKGSK plc
04/25/20236:35AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
04/20/202310:54AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
04/19/202311:10AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
04/18/202312:11PMBusiness WireGSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS HealthNYSE:GSKGSK plc
04/18/202310:42AMDow Jones NewsBellus Health Toronto-Listed Shares Double on GSK TakeoverNYSE:GSKGSK plc
04/18/20237:55AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
04/18/20236:30AMDow Jones NewsTrending: GSK Buys Bellus Health for About $2 BillionNYSE:GSKGSK plc
04/18/20236:24AMDow Jones NewsBellus Health Shares Soar Premarket on Takeover by GSKNYSE:GSKGSK plc
04/18/20232:48AMDow Jones NewsGSK to Acquire Canadian BELLUS Health for Around $2 BillionNYSE:GSKGSK plc
04/17/20236:34AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
04/17/20232:51AMDow Jones NewsGSK Reports Positive Phase 3 Data for UTI Oral AntibioticNYSE:GSKGSK plc
04/03/20238:11AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
03/30/202310:43AMDow Jones NewsScynexis Shares Jump 60% After Licensing Deal With GSKNYSE:GSKGSK plc
03/28/20238:01AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
03/27/20236:21PMPR Newswire (US)Phase III RUBY clinical trial demonstrates potential of Jemperli (dostarlimab-gxly) plus chemotherapy to redefine the treatment of primary advanced or recurrent endometrial cancer versus chemotherapy aloneNYSE:GSKGSK plc
03/27/20238:52AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
03/24/20238:30AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
03/24/20236:52AMDow Jones NewsGSK Disagrees With Court Ruling to Allow Plaintiff-Expert Testimony in Goetz CaseNYSE:GSKGSK plc
03/20/202311:42AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
03/14/20236:51PMDow Jones NewsADRs End Higher; Credit Suisse, GSK Trade ActivelyNYSE:GSKGSK plc
03/14/202312:00PMBusiness WireGSK and Earvin “Magic” Johnson Partner to Raise Awareness of Risk of RSV in Older AdultsNYSE:GSKGSK plc
 Showing the most relevant articles for your search:NYSE:GSK

Your Recent History

USOTC
MONI
Moon Equity (PK)
USOTC
AABB
Asia Broadband (PK)
USOTC
RONN
Ronn Motor (PK)
USOTC
CYDY
CytoDyn (QB)
USOTC
WDLF
Decentral Life (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
SFRX
Seafarer Exploration (PK)
NASDAQ
AMRN
Amarin
USOTC
CNNA
Cann American (CE)
USOTC
GDVM
Global Developments (PK)
USOTC
TPTW
TPT Global Tech (PK)
USOTC
RNVA
Rennova Health (PK)
USOTC
RDGL
Vivos (QB)
NASDAQ
MAXN
Maxeon Solar Technologies
USOTC
CLNV
Clean Vision (QB)
AMEX
SPY
SPDR S&P 500
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved